# Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis

> **NCT05578482** · PHASE4 · UNKNOWN · sponsor: **Jacob Pontoppidan Thyssen** · enrollment: 45 (estimated)

## Conditions studied

- Atopic Dermatitis
- Atopic Dermatitis Eczema
- Atopic Dermatitis Flare

## Interventions

- **DRUG:** Dicloxacillin Oral Capsule
- **DRUG:** Elocon 0.1 % Topical Cream

## Key facts

- **NCT ID:** NCT05578482
- **Lead sponsor:** Jacob Pontoppidan Thyssen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-24
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05578482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05578482, "Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05578482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*